| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Dec-08 | 30-Sep-08 | | Total Revenue | 3,410 | 5,200 | 13,113 | 16,040 | | Cost of Revenue | 2,472 | 3,892 | 10,811 | 13,350 | | | Gross Profit | 938 | 1,308 | 2,302 | 2,689 | | | Operating Expenses | | Research Development | 667 |
-
|
-
|
-
| | Selling General and Administrative | 3,622 | 3,400 | 5,612 | 6,333 | | Non Recurring |
-
|
-
|
-
|
-
| | Others | 373 | 457 | 728 | 725 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | (3,724) | (2,549) | (4,038) | (4,369) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 1,040 | 12 | 6 | 9 | | Earnings Before Interest And Taxes | (3,683) | (2,537) | (4,032) | (4,359) | | Interest Expense | (455) | 455 | 537 | 520 | | Income Before Tax | (3,228) | (2,991) | (4,569) | (4,879) | | Income Tax Expense |
-
|
-
| (158) | (956) | | Minority Interest |
-
|
-
| 154 | 173 | | | | Net Income From Continuing Ops | (3,200) | (2,991) | (4,257) | (3,751) | | | Non-recurring Events | | Discontinued Operations | (1,023) | (1,008) |
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (4,223) | (3,999) | (4,257) | (3,751) | | Preferred Stock And Other Adjustments | (263) | 135 | (138) | (138) | | | Net Income Applicable To Common Shares | ($4,485) | ($3,863) | ($4,395) | ($3,889) |
|
0.51% Nasdaq 
Income Statement
